| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 32.56 | 0.58 (+1.81%) | 14.82 - 33.04 | 132.2 thousand (Above Avg) |
Market data as of 9:51AM 05/22/13. Quotes are delayed by at least 15 min.
| Open | 31.94 |
|---|---|
| Previous Close | 31.98 |
| Day's Range | 31.50 - 32.90 |
| Market Cap | 4.3B |
| Avg Volume (10 Day) | 1.3M |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.37 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53rd Annual NCDEU Meeting
Business Wire - Wednesday 05/22/2013 7:00 AM ET
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013
Business Wire - Thursday 05/16/2013 4:00 PM ET
Alkermes Elects Nancy Wysenski to Board of Directors
Business Wire - Thursday 05/16/2013 7:00 AM ET
Alkermes’ Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference
Business Wire - Wednesday 05/01/2013 4:00 PM ET
| ALKS | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 74.67% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.40 | |
| LT Debt/Equity | 0.39 | |
| Earnings Yield | -- | |
| Price/Sales | 7.85 |
| Company | Last | Change |
|---|---|---|
| Hospira Inc | 36.10 | +0.51% |
| Elan Corporation PLC | 12.08 | +0.08% |
| PetMed Express Inc | 13.45 | +1.05% |
| Flamel Technologies SA | 4.61 | -0.86% |
| Acura Pharmaceuticals Inc | 2.33 | +1.20% |
Data is delayed by at least 15 min.